Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-25-114799
Filing Date
2025-11-21
Accepted
2025-11-21 08:06:49
Documents
1
Effectiveness Date
2025-11-21

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2531793d4_s8pos.htm S-8 POS 21704
  Complete submission text file 0001104659-25-114799.txt   22865
Mailing Address YALELAAN 62 UTRECHT Netherlands
Business Address YALELAAN 62 UTRECHT Netherlands 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-286228 | Film No.: 251504656
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)